Latest Europe News

BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.

Vulcan Energy has kicked off civil construction at its Lionheart geothermal power plant in Landau, marking a key milestone in its integrated lithium and renewable energy project targeting 24,000 tonnes of lithium hydroxide annually.

Argosy Minerals is progressing its 12,000tpa Rincon Lithium Project in Argentina with robust feasibility testwork validating its process flowsheet and securing a 40MW power supply, underpinning its upcoming Definitive Feasibility Study.

Argenica Therapeutics is gearing up for a pivotal late-stage clinical trial of its neuroprotective drug ARG-007 (xaranetide) in acute ischaemic stroke, backed by strong safety assays and solid funding.

RareX Limited and Iluka Resources have progressed to the Request for Proposal stage for the Mrima Hill Niobium and Rare Earths Project in Kenya, backed by a A$1.65 billion Australian Government loan for downstream refining.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Elementos Limited made significant strides in advancing its Oropesa Tin Project in Spain, securing key permitting milestones and expanding exploration tenure while strengthening its vertical integration strategy in Europe. Concurrent progress at its Cleveland project in Tasmania and a robust cash position underpin the company’s push toward a Final Investment Decision amid elevated tin prices.

Karoon Energy delivered a solid second quarter with 1.08 million barrels of oil equivalent produced and US$116.4 million in sales, underpinned by higher oil prices and operational milestones at Baúna and Who Dat. The company is progressing strategic growth projects and share buybacks while navigating extended Brazilian export taxes.

Krakatoa Resources is pushing its 2026 drilling program at the Zopkhito Antimony-Gold Project two months ahead of schedule, advancing toward a maiden JORC-compliant mineral resource estimate with multiple technical workstreams underway.

CLINUVEL Pharmaceuticals is relocating its corporate headquarters to the United States and reducing its global workforce by up to 20%, realigning its operations to focus solely on the US pharmaceutical market and unlock greater capital access.

Credit Clear Limited has posted a 28% revenue increase to $60 million and a 41% jump in underlying EBITDA to $10.4 million for FY26, beating guidance and driven by organic growth and recent acquisitions in Europe and debt collection.

OFX Group has accepted a recommended all-cash takeover bid from UK-based Equals at $1.00 per share, more than doubling its share price from early February. The deal values OFX at $247 million equity and hinges on due diligence, debt financing, and shareholder approval, while the company reports steady growth in its corporate payments business and strong non-FX revenue.